

![]() |
TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort |
|
Authors | ![]() | |
Published in | Annals of the rheumatic diseases. 2018, vol. 77, no. 1, p. 63-69 | |
Abstract | To analyse the impact of tumour necrosis factor inhibitors (TNFis) on spinal radiographic progression in ankylosing spondylitis (AS). | |
Keywords | Adult — Axis, Cervical Vertebra/diagnostic imaging/pathology — Cohort Studies — Disease Progression — Female — Follow-Up Studies — Humans — Lumbar Vertebrae/diagnostic imaging/pathology — Male — Middle Aged — Multivariate Analysis — Radiography — Severity of Illness Index — Spine/diagnostic imaging/pathology — Spondylitis, Ankylosing/diagnostic imaging/drug therapy/pathology — Switzerland — Treatment Outcome — Tumor Necrosis Factor-alpha/antagonists & inhibitors | |
Identifiers | PMID: 28939631 | |
Full text | ||
Structures | ||
Research groups | Mécanisme de l'inflammation articulaire (44) Recherche clinique en rhumatismes inflammatoires (1010) | |
Citation (ISO format) | MOLNAR, Christoph et al. TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort. In: Annals of the Rheumatic Diseases, 2018, vol. 77, n° 1, p. 63-69. doi: 10.1136/annrheumdis-2017-211544 https://archive-ouverte.unige.ch/unige:110919 |